Fellow Health Closes a $24 Million Series B Financing to Expand its Male Reproductive Test Offerings

Fellow Health完成2400万美元B轮融资，扩大其男性生殖检测产品线

Capital will be used to scale mail-in semen analysis and expand its market offerings

资本将用于扩大邮寄精液分析业务并扩展其市场产品。

SAN LEANDRO, Calif., July 15, 2025-- Fellow Health, a leading company focused on advancing male reproductive health through patient-centric testing solutions, announced today the close of a $24 million Series B financing round. The round was led by 5AM Ventures, with new participation from The Forest Road Company (Forest Road).

加利福尼亚州圣莱安德罗，2025年7月15日——Fellow Health是一家致力于通过以患者为中心的检测解决方案推动男性生殖健康发展的领先公司，今天宣布完成了2400万美元的B轮融资。本轮融资由5AM Ventures领投，The Forest Road Company（Forest Road）新加入参与。

The Series B adds to Fellow Health’s prior Series A and follow-on funding, bringing the company’s total capital raised to $48 million across all rounds..

B轮融资为Fellow Health先前的A轮融资和后续融资增添了资金，使得该公司在所有轮融资中筹集的总资本达到了4800万美元。

The funding will accelerate Fellow Health’s expansion of its mail-in semen analysis services, including fertility and post-vasectomy testing, through continued growth of its clinical partner network now spanning more than 2,500 fertility and urology practices nationwide. The company will leverage insights from its success in urology practices to deepen its footprint in fertility, with planned expansions into employer-sponsored fertility benefits and broader access initiatives.

这笔资金将加速Fellow Health扩展其邮寄精液分析服务，包括生育能力和输精管切除术后测试，通过持续发展其临床合作伙伴网络，该网络目前已覆盖全国超过2500家生育和泌尿科诊所。该公司将利用其在泌尿科领域取得成功的经验，进一步深耕生育领域，并计划扩展至雇主资助的生育福利以及更广泛的服务获取计划。

As part of the financing, Bill Burkoth of Forest Road will join Fellow Health’s Board of Directors..

作为融资的一部分，Forest Road的比尔·伯克霍夫将加入Fellow Health的董事会。

The demand for male reproductive care continues to rise, yet traditional testing methods remain archaic, inconvenient, and clinic bound. Fellow Health provides clinical grade, mail-in testing that gives patients privacy, convenience, and timely results while also reducing the burden on healthcare providers..

男性生殖健康需求持续增长，但传统的检测方法依然古老、不便且局限于诊所。Fellow Health 提供临床级别的邮寄检测服务，为患者提供隐私保护、便捷性和及时的结果，同时减轻了医疗保健提供者的负担。

“Male reproductive health shouldn’t be reactive or inaccessible,” said Brian Hogan, CEO of Fellow Health. “We are on track to deliver over 40% year-over-year revenue growth, with a path to profitability in our fertility segment by 2026. This investment allows us to scale that vision and support both patients and providers with modern tools that work.”.

“男性生殖健康不应该被动应对或难以获取，”Fellow Health首席执行官布莱恩·霍根表示。“我们有望实现超过40%的年收入增长，并在2026年之前使我们的生育领域实现盈利。这项投资使我们能够扩展这一愿景，并通过现代化的有效工具支持患者和医疗服务提供者。”

“Fellow Health is exactly the kind of company we look for—operating in a large, overlooked market that’s long overdue for disruption,” said Bill Burkoth, Managing Partner, Life Sciences, Forest Road. “With over 50,000 test results delivered so far this year, they’ve proven there is real demand for a better patient experience.”.

“Fellow Health 正是我们寻找的那种公司——在一个庞大且被忽视的市场中运营，这个市场早就应该迎来颠覆，”Forest Road 生命科学管理合伙人比尔·伯克霍夫表示。“今年迄今为止，他们已经交付了超过50,000份检测结果，这证明了人们对于更好的患者体验确实存在需求。”

“At 5AM, we back science that redefines what’s possible in healthcare, and Fellow Health is doing exactly that,” said Andy Schwab, Managing Partner of 5AM Ventures and Fellow Health Board Member. “They’ve taken a traditionally overlooked segment of reproductive health and applied the same rigor and precision that occurs at a traditional clinic.

“凌晨5点，我们支持重新定义医疗保健领域可能性的科学，而Fellow Health正是在这样做，”5AM Ventures管理合伙人兼Fellow Health董事会成员安迪·施瓦布表示。“他们采用了一个传统上被忽视的生殖健康领域，并应用了与传统诊所相同的严谨和精确性。”

The result is a platform that is shifting the standard of care.”.

结果是一个正在改变护理标准的平台。

About Fellow Health

关于同仁健康

Founded in 2018, Fellow Health is a leading company dedicated to advancing male reproductive health through innovative and comprehensive mail-in testing solutions. The company partners with more than 1,800 top clinical practices, processing over 400 patient samples daily through their CLIA-certified lab, and is the only mail-in fertility test with peer-reviewed validation data.

成立于2018年，Fellow Health是一家致力于通过创新和全面的邮寄检测解决方案推动男性生殖健康的领先公司。该公司与1800多家顶级临床机构合作，每天通过其CLIA认证实验室处理超过400份患者样本，并且是唯一拥有经同行评议验证数据的邮寄生育能力检测公司。

Fellow Health has secured funding from leading life sciences and technology investors, including 5AM Ventures, Forest Road, Labcorp Venture Fund, Genoa Ventures, and Mantis Venture Capital..

Fellow Health 已获得来自领先生命科学和技术投资者的融资，包括 5AM Ventures、Forest Road、Labcorp 风险基金、Genoa Ventures 和 Mantis 风险资本。

About 5AM Ventures

关于5AM Ventures

Founded in 2002, 5AM Ventures is a leading venture capital firm focused on investing in and building next-generation life science companies. Based in San Francisco, Boston, and New York City, 5AM takes a hands-on approach to investing and company building, often going beyond traditional board roles to leverage our diverse team of scientists, clinicians, drug developers and executives throughout a company’s life.

成立于2002年，5AM Ventures是一家领先的风险投资公司，专注于投资和打造下一代生命科学企业。总部位于旧金山、波士顿和纽约市，5AM采取亲力亲为的投资和公司建设方式，常常超越传统的董事会角色，利用我们由科学家、临床医生、药物开发人员和高管组成的多元化团队，贯穿公司的整个生命周期。

With more than $2.2 billion raised since inception, 5AM has invested globally in over 140 public and private companies..

自成立以来，5AM已筹集超过22亿美元的资金，并在全球范围内投资了140多家上市公司和私营公司。

5AM has helped guide portfolio companies to meaningful value-accretive outcomes. Across the 5AM funds, over 30 portfolio companies have entered the public markets (e.g., through IPOs) and over 20 portfolio companies have been acquired through M&A. A full list of portfolio companies, including those companies which have entered the public markets or been exited through M&A, are available on our website..

5AM帮助引导其投资组合公司实现了有意义的价值增长成果。在5AM基金的投资组合中，已有超过30家投资组合公司进入公开市场（例如，通过IPO），超过20家投资组合公司通过并购被收购。投资组合公司的完整列表，包括那些已进入公开市场或通过并购退出的公司，都可以在我们的网站上找到。

For more information, please visit www.5amventures.com.

欲了解更多信息，请访问 www.5amventures.com。

About The Forest Road Company

关于森林之路公司

The Forest Road Company is an investment firm that capitalizes on market inefficiencies through niche and esoteric strategies designed to capture attractive alpha. The firm operates across three core verticals: Forest Road Asset Management (FRAM), an SEC-registered investment adviser that manages funds across transformative sectors; Forest Road Securities, which includes an FCA-registered investment bank and a FINRA-registered broker-dealer; and a portfolio of operating companies and for-control investments.

森林之路公司是一家投资公司，通过设计用来获取有吸引力的阿尔法收益的小众和深奥策略，利用市场低效。该公司在三个核心领域开展业务：森林之路资产管理（FRAM），这是一家在美国证券交易委员会注册的投资顾问，管理着横跨变革性行业的基金；森林之路证券，包括一家在英国金融行为监管局注册的投资银行和一家在美国金融业监管局注册的经纪交易商；以及一个由运营公司和控股投资组成的投资组合。

With over 800 transactions and $2 billion in deployed capital, Forest Road leverages deep institutional and family office networks to create value across its integrated platform. For more information, visit www.forestroadco.com..

通过超过800笔交易和部署的20亿美元资本，Forest Road利用深厚的机构和家族办公室网络，在其综合平台上创造价值。欲了解更多信息，请访问www.forestroadco.com。

Contact:

联系人：

Media Contact

媒体联系人

media@meetfellow.com

媒体@meetfellow.com